FDA Approves Eli Lilly’s GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Devices Target the Gut to Maintain Weight Loss from GLP-1 Drugs
Christina had tried dieting and exercise before. The weight always came off but then crept back on, especially after she gave birth to her son in 2022.She had hoped that a new class of weight-loss drugs might finally offer something different. Obesity…